Ellipses Pharma, a cancer drug venture, is reportedly preparing to list on the London Stock Exchange. The clinical-stage oncology company, founded by British biotech entrepreneur Sir Chris Evans, is targeting a listing valuation of between £450m and £500m.
The venture's investors include Sir Chris Evans, housebuilder founder Steve Morgan, and Sir Tom Hunter’s West Coast Capital. Comedian Jimmy Carr and Andrew Lloyd Webber are also among the celebrity investors. Abu Dhabi’s sovereign wealth fund is the single largest investor, holding a 45% stake.
Ellipses is planning a London listing as soon as February through a reverse takeover of Wolfram Resources. This move follows earlier considerations of listing on the Nasdaq or in Hong Kong in 2025. Berenberg is reported to be assisting with the deal, and Ellipses is also preparing to appoint non-executives to its board.